$CBRS

Cerebras Stock Slumps After Earnings -- Analysts See 'Buying Opportunity'

Cerebras Systems (CBRS) shares dropped after its Q2 results. The company reported $180.1M revenue, up over 70% YoY, with an adjusted loss of $6.91M versus about $41M expected, and a net loss of $450.5M. It raised FY2026 core revenue guidance to $880M-$890M and Q3 to $214M-$216M. Analysts kept bullish stances, raising price targets (Wedbush to $290, Morgan Stanley to $279) despite the selloff.

Original reporting
Published Aug 13, 2026, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 7:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cerebras Stock Slumps After Earnings -- Analysts See 'Buying Opportunity' — source image
Decision brief

The 30-second read

$CBRSNeutralMed
01

Why it matters

The key trade tension is whether the market is repricing near-term hardware-sales pressure versus accepting the improved core revenue trajectory.

02

Market read

This is a post-earnings guidance and sentiment reset for CBRS, with raised revenue outlook not preventing a sharp selloff.

03

What to watch

The article does not quantify gross margin, cash burn, or backlog quality; traders may need to verify whether the narrower adjusted loss came from one-offs or cost timing that may not persist.

Relevance 7/10Novelty 7/10Timing: post-earnings reaction on Thursday

Background

Cerebras reported Q2 revenue growth and guided FY2026 core revenue higher, but the stock sold off sharply after the report.

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras shares fell double digits after Q2 results and guidance, including raised FY2026 core revenue outlook and a Q3 core revenue forecast above expectations.

Expected impact

Near-term volatility likely persists as investors weigh elevated expectations and hardware-sales pressure against improved revenue guidance.

Evidence & confidence

The article cites both the negative catalyst (double-digit drop post-report) and the offsetting positives (raised FY2026 core revenue outlook, Q3 forecast above expectations), implying mixed market interpretation rather than a clean beat-and-raise.

Market effects

Highlights investor sensitivity to AI hardware sales expectations even when revenue guidance improves, which can affect sentiment across AI accelerator names.

No specific regional spillover beyond US-listed AI chip/semis sentiment.

Limited; the disclosed facts are company-specific and do not indicate a broader global supply or demand shock.

Counterpoint

The raised FY2026 and Q3 core revenue outlook suggests the selloff may be expectation-driven rather than fundamentals deteriorating, creating a potential mean-reversion setup if hardware-sales concerns fade.

Key entities

  • Cerebras Systems

    AI chipmaker whose Q2 results and raised core revenue outlook triggered a double-digit stock decline.

  • Wedbush

    Raised its price target to $290 from $280 and maintained a bullish stance.

  • Morgan Stanley

    Lifted its target to $279 from $273.

  • Citi

    Maintained Buy rating but cut its target to $320 from $340.

  • Needham

    Kept a Buy rating and $300 target.

Related articles

$CBRSMedAI 8/10

Why Cerebras Systems Stock Just Sank

Cerebras Systems (CBRS) shares fell about 11.9% on Thursday after its Q2 report, which came in below Wall Street expectations. The company posted a net loss of $2.98 per share on revenue of $180.11 million, with revenue about $13.4 million under forecasts. It raised full-year sales and margin targets.

$CBRSMedAI 8/10

Cerebras Systems’ Stock Falls 17% On Mixed Financial Results

Cerebras Systems (CBRS) shares fell 17% after its second earnings report as a public company. The company posted EPS loss of -$0.05 vs -$0.17 expected, but revenue was $180M vs $194M forecast. Net loss was $450.5M. It guided current-quarter revenue to $214M-$216M and full-year to $880M-$890M. Cerebras cited $25.4B backlog.

$CBRSMedAI 8/10

Cerebras Raised Guidance but Still Lost a Fifth of Its Value

Cerebras Systems (CBRS) shares fell premarket after Q2 GAAP revenue of $180.1M missed the $194M consensus. The company reported $209.9M core revenue, excluding pass-through revenue and adding back warrant amortization. Cloud and other services rose to $126.0M, while hardware fell to $54.1M. GAAP net loss was $450.5M ($2.98/share). Full-year core guidance increased to $880M-$890M.